Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxygen transport via extracellular hemoglobin refers to the process by which hemoglobin molecules, located outside of red blood cells (RBCs), bind and deliver oxygen to tissues. While in most vertebrates, hemoglobin is contained within RBCs, some organisms (such as certain annelids like lugworms) possess large, multi-subunit extracellular hemoglobins that circulate freely in the plasma. Additionally, under pathological or experimental conditions in humans and other mammals, free (extracellular) hemoglobin can be present due to RBC lysis or as engineered oxygen carriers. When free/extracellular Hb appears in human plasma due to cell lysis or transfusion products, it can scavenge nitric oxide (NO), disrupting vascular tone regulation and leading to vasoconstriction or hypertension. It undergoes autoxidation more readily than intracellular Hb, generating reactive oxygen species (ROS) such as superoxide and hydrogen peroxide, increasing oxidative stress if not neutralized by antioxidants or scavenger proteins like haptoglobin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Hemoglobin (Extracellular Hb).